Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Hormone Sensitive Prostate Cancer”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableStudy completedNCT02229253
What this trial is testing

Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

Who this might be right for
Advanced Hormone Sensitive Prostate Cancer
Ferring Pharmaceuticals 112
Large-scale testing (Phase 3)Active Not RecruitingNCT04821622
What this trial is testing

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Who this might be right for
Prostate Cancer
Pfizer 599
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Large-scale testing (Phase 3)Not Yet RecruitingNCT06837896
What this trial is testing

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 110
Very early researchActive Not RecruitingNCT03511196
What this trial is testing

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Who this might be right for
Prostate CancerStage IV Prostate CancerAdvanced Prostate Cancer+1 more
H. Lee Moffitt Cancer Center and Research Institute 17
Not applicableNot Yet RecruitingNCT07344779
What this trial is testing

Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Bayer 1,600
Early research (Phase 1)Looking for participantsNCT04729114
What this trial is testing

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration Resistant Prostate CancerMetastatic Castration-sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 174
Not applicableNot Yet RecruitingNCT07395804
What this trial is testing

How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Bayer 500
Early research (Phase 1)Not Yet RecruitingNCT07339267
What this trial is testing

Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07005154
What this trial is testing

Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 218
Large-scale testing (Phase 3)Study completedNCT00242567
What this trial is testing

Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 522
Not applicableUnknownNCT04220398
What this trial is testing

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate CancerChemotherapy EffectHormone Sensitive Prostate Cancer+1 more
RenJi Hospital 475
Testing effectiveness (Phase 2)Active Not RecruitingNCT06463457
What this trial is testing

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Who this might be right for
Prostate CancerAdvanced Prostate CancerHormone Sensitive Prostate Cancer
Atish Choudhury, MD 33